L-citrulline supplementation in the treatment of pulmonary hypertension associated with bronchopulmonary dysplasia in preterm infant: A case report
Introduction: the aim of this case report is to present that oral L-citrulline supplementation may attenuate chronic pulmonary hypertension and reduce oxygen requirement in infants with severe bronchopulmonary dysplasia. Important clinical findings: a boy, with a birth weight of 700 g, born by cesar...
Main Authors: | Ryszard Lauterbach, Dorota Pawlik, Jan Paweł Lauterbach |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2018-05-01
|
Series: | SAGE Open Medical Case Reports |
Online Access: | https://doi.org/10.1177/2050313X18778730 |
Similar Items
-
Pulmonary hypertension in infants with bronchopulmonary dysplasia
by: Gi Beom Kim
Published: (2010-06-01) -
Biomarkers for Bronchopulmonary Dysplasia in the Preterm Infant
by: Lidys eRivera, et al.
Published: (2016-03-01) -
B-type natriuretic peptide is a biomarker for pulmonary hypertension in preterm infants with bronchopulmonary dysplasia
by: Cuna A, et al.
Published: (2013-05-01) -
Early pulmonary hypertension is a risk factor for bronchopulmonary dysplasia-associated late pulmonary hypertension in extremely preterm infants
by: Hyun Ho Kim, et al.
Published: (2021-05-01) -
Development of a proxy-reported pulmonary outcome scale for preterm infants with bronchopulmonary dysplasia
by: Laughon Matthew M, et al.
Published: (2011-07-01)